ArticleExperimental and therapeutic medicine2017

Vandetanib and ADAM inhibitors synergistically attenuate the pathological migration of EBV-infected retinal pigment epithelial cells by regulating the VEGF-mediated MAPK pathway.

Daejin Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.